MUSTANG BIO INC (MBIO)
US62818Q2030 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A 405.45% | N/A 128.59% | N/A 41.94% | N/A 40.41% | ||||||||||
| EBITDA YoY % growth | N/A | N/A | -31.79M | -30.59M 3.77% | -44.63M -45.90% | -55.13M -23.53% | -64.55M -17.09% | -73.44M -13.77% | -48.866M 33.46% | N/A 53.45% | N/A 3.14% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -4.3M | -11.36M -164.19% | -31.79M -179.84% | -31.22M 1.79% | -45.89M -46.99% | -56.81M -23.80% | -66.72M -17.44% | -76.16M -14.15% | -50.726M 33.40% | N/A 58.98% | N/A -5.88% | N/A -223.61% | N/A 46.92% | N/A 157.41% | N/A 201.41% | N/A 92.52% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -1.15 -29.59% | -1.30 -13.04% | -1.15 11.54% | -3.84 -233.91% | -11.25 -192.97% | -6.32 43.82% | N/A 90.16% | N/A 42.62% | N/A -465.71% | N/A 47.98% | N/A 157.28% | N/A 201.69% | N/A 92.13% |
All data in USD
| Q4 / 24 | |
|---|---|
| EPS Q2Q % growth | -0.16 81.02% |
| Revenue Q2Q % growth | |
| EBITDA Q2Q % growth | -6.528M 6.69% |
| EBIT Q2Q % growth | -10.169M -14.83% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.04 97.14% | -0.13 | 0.09 | 69.83% |
| Q2 2024 Q2Q % growth | 55.12% | -0.90 | % | |
| Q1 2024 Q2Q % growth | 56.92% | -0.89 | % | |
| Q4 2023 Q2Q % growth | -0.86 68.15% | -1.36 | 0.50 | 36.61% |
| Q3 2023 Q2Q % growth | -1.40 48.15% | -1.30 | -0.10 | -7.65% |
| Q2 2023 Q2Q % growth | -2.00 29.82% | -1.84 | -0.16 | -8.48% |
| Q1 2023 Q2Q % growth | -2.06 31.33% | -3.07 | 1.01 | 32.90% |
| Q4 2022 Q2Q % growth | -2.70 18.18% | -2.95 | 0.25 | 8.33% |
| Q3 2022 Q2Q % growth | -2.70 -1,321.05% | -3.02 | 0.32 | 10.65% |
| Q2 2022 Q2Q % growth | -2.85 -1,681.25% | -3.18 | 0.33 | 10.44% |
| Q1 2022 Q2Q % growth | -3.00 -1,478.95% | -2.82 | -0.18 | -6.56% |
| Q4 2021 Q2Q % growth | -3.30 -931.25% | -2.94 | -0.36 | -12.34% |
| Q3 2021 Q2Q % growth | -0.19 17.39% | -0.18 | -0.01 | -4.65% |
| Q2 2021 Q2Q % growth | -0.16 50.00% | -0.20 | 0.04 | 20.58% |
| Q1 2021 Q2Q % growth | -0.19 32.14% | -0.20 | 0.01 | 4.47% |
| Q4 2020 Q2Q % growth | -0.32 23.81% | -0.21 | -0.11 | -51.19% |
| Q3 2020 Q2Q % growth | -0.23 8.00% | -0.26 | 0.02 | 9.80% |
| Q2 2020 Q2Q % growth | -0.32 -10.34% | -0.27 | -0.05 | -17.65% |
| Q1 2020 Q2Q % growth | -0.28 17.65% | -0.31 | 0.03 | 10.49% |
| Q4 2019 Q2Q % growth | -0.42 | -0.27 | -0.15 | -56.37% |
| Q3 2019 Q2Q % growth | -0.25 | -0.27 | 0.02 | 6.92% |
| Q2 2019 Q2Q % growth | -0.29 | -0.26 | -0.03 | -12.23% |
| Q1 2019 Q2Q % growth | -0.34 | -0.37 | 0.03 | 8.68% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 82.61% | 0% | 82.91% |
| Revenue | N/A | N/A | N/A | N/A |